Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

CVC Income & Growth (CVCE) Competitors

GBX 1.05 +0.01 (+0.96%)
As of 12:22 PM Eastern

CVCE vs. HOYE, MILA, TFG, BPCR, and USG

Should you buy CVC Income & Growth stock or one of its competitors? MarketBeat compares CVC Income & Growth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CVC Income & Growth include Honye Financial Services (HOYE), Mila Resources (MILA), Tetragon Financial (TFG), BioPharma Credit (BPCR), and Ultimate Sports Group (USG). These companies are all part of the "asset management" industry.

How does CVC Income & Growth compare to Honye Financial Services?

Honye Financial Services (LON:HOYE) and CVC Income & Growth (LON:CVCE) are both small-cap financial services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

In the previous week, Honye Financial Services' average media sentiment score of 0.00 equaled CVC Income & Growth'saverage media sentiment score.

Company Overall Sentiment
Honye Financial Services Neutral
CVC Income & Growth Neutral

Honye Financial Services has a net margin of 0.00% compared to CVC Income & Growth's net margin of -20.03%. CVC Income & Growth's return on equity of -2.11% beat Honye Financial Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Honye Financial ServicesN/A -104.63% -34.81%
CVC Income & Growth -20.03%-2.11%N/A

2.9% of CVC Income & Growth shares are held by institutional investors. 9.5% of Honye Financial Services shares are held by insiders. Comparatively, 0.1% of CVC Income & Growth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CVC Income & Growth is trading at a lower price-to-earnings ratio than Honye Financial Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Honye Financial ServicesN/AN/AN/A-£0.01N/A
CVC Income & Growth£18.73M0.16N/A-£4.94N/A

Summary

CVC Income & Growth beats Honye Financial Services on 5 of the 8 factors compared between the two stocks.

How does CVC Income & Growth compare to Mila Resources?

Mila Resources (LON:MILA) and CVC Income & Growth (LON:CVCE) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

2.5% of Mila Resources shares are held by institutional investors. Comparatively, 2.9% of CVC Income & Growth shares are held by institutional investors. 4.8% of Mila Resources shares are held by insiders. Comparatively, 0.1% of CVC Income & Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Mila Resources had 1 more articles in the media than CVC Income & Growth. MarketBeat recorded 1 mentions for Mila Resources and 0 mentions for CVC Income & Growth. Mila Resources' average media sentiment score of 0.75 beat CVC Income & Growth's score of 0.00 indicating that Mila Resources is being referred to more favorably in the media.

Company Overall Sentiment
Mila Resources Positive
CVC Income & Growth Neutral

Mila Resources has a net margin of 0.00% compared to CVC Income & Growth's net margin of -20.03%. CVC Income & Growth's return on equity of -2.11% beat Mila Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Mila ResourcesN/A -9.96% -5.89%
CVC Income & Growth -20.03%-2.11%N/A

Mila Resources has a beta of 1.6345071, indicating that its share price is 63% more volatile than the broader market. Comparatively, CVC Income & Growth has a beta of 0.18503673, indicating that its share price is 81% less volatile than the broader market.

CVC Income & Growth has higher revenue and earnings than Mila Resources. Mila Resources is trading at a lower price-to-earnings ratio than CVC Income & Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mila ResourcesN/AN/A-£364.80K-£0.12N/A
CVC Income & Growth£18.73M0.16N/A-£4.94N/A

Summary

Mila Resources beats CVC Income & Growth on 6 of the 11 factors compared between the two stocks.

How does CVC Income & Growth compare to Tetragon Financial?

CVC Income & Growth (LON:CVCE) and Tetragon Financial (LON:TFG) are both small-cap financial services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

In the previous week, CVC Income & Growth's average media sentiment score of 0.00 equaled Tetragon Financial'saverage media sentiment score.

Company Overall Sentiment
CVC Income & Growth Neutral
Tetragon Financial Neutral

Tetragon Financial has a net margin of 70.54% compared to CVC Income & Growth's net margin of -20.03%. Tetragon Financial's return on equity of 19.70% beat CVC Income & Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
CVC Income & Growth-20.03% -2.11% N/A
Tetragon Financial 70.54%19.70%3.14%

Tetragon Financial has higher revenue and earnings than CVC Income & Growth. CVC Income & Growth is trading at a lower price-to-earnings ratio than Tetragon Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVC Income & Growth£18.73M0.16N/A-£4.94N/A
Tetragon Financial£751.20M0.01£12.66B£759.000.02

CVC Income & Growth pays an annual dividend of GBX 7.49 per share and has a dividend yield of 713.0%. Tetragon Financial pays an annual dividend of GBX 44 per share and has a dividend yield of 341.1%. CVC Income & Growth pays out -151.5% of its earnings in the form of a dividend. Tetragon Financial pays out 5.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVC Income & Growth is clearly the better dividend stock, given its higher yield and lower payout ratio.

2.9% of CVC Income & Growth shares are held by institutional investors. Comparatively, 1.0% of Tetragon Financial shares are held by institutional investors. 0.1% of CVC Income & Growth shares are held by insiders. Comparatively, 30.8% of Tetragon Financial shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CVC Income & Growth has a beta of 0.18503673, indicating that its share price is 81% less volatile than the broader market. Comparatively, Tetragon Financial has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market.

Summary

Tetragon Financial beats CVC Income & Growth on 8 of the 12 factors compared between the two stocks.

How does CVC Income & Growth compare to BioPharma Credit?

CVC Income & Growth (LON:CVCE) and BioPharma Credit (LON:BPCR) are both small-cap financial services companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

CVC Income & Growth has a beta of 0.18503673, meaning that its share price is 81% less volatile than the broader market. Comparatively, BioPharma Credit has a beta of 0.2134515, meaning that its share price is 79% less volatile than the broader market.

BioPharma Credit has higher revenue and earnings than CVC Income & Growth. CVC Income & Growth is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVC Income & Growth£18.73M0.16N/A-£4.94N/A
BioPharma Credit£132.06M0.08£10.42B£11.400.08

CVC Income & Growth pays an annual dividend of GBX 7.49 per share and has a dividend yield of 713.0%. BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 735.3%. CVC Income & Growth pays out -151.5% of its earnings in the form of a dividend. BioPharma Credit pays out 61.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, CVC Income & Growth's average media sentiment score of 0.00 equaled BioPharma Credit'saverage media sentiment score.

Company Overall Sentiment
CVC Income & Growth Neutral
BioPharma Credit Neutral

2.9% of CVC Income & Growth shares are owned by institutional investors. Comparatively, 27.0% of BioPharma Credit shares are owned by institutional investors. 0.1% of CVC Income & Growth shares are owned by insiders. Comparatively, 0.1% of BioPharma Credit shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

BioPharma Credit has a net margin of 92.62% compared to CVC Income & Growth's net margin of -20.03%. BioPharma Credit's return on equity of 11.29% beat CVC Income & Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
CVC Income & Growth-20.03% -2.11% N/A
BioPharma Credit 92.62%11.29%4.98%

Summary

BioPharma Credit beats CVC Income & Growth on 9 of the 12 factors compared between the two stocks.

How does CVC Income & Growth compare to Ultimate Sports Group?

CVC Income & Growth (LON:CVCE) and Ultimate Sports Group (LON:USG) are both small-cap asset management industry companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

In the previous week, CVC Income & Growth's average media sentiment score of 0.00 equaled Ultimate Sports Group'saverage media sentiment score.

Company Overall Sentiment
CVC Income & Growth Neutral
Ultimate Sports Group Neutral

Ultimate Sports Group has a net margin of 0.00% compared to CVC Income & Growth's net margin of -20.03%. Ultimate Sports Group's return on equity of 0.00% beat CVC Income & Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
CVC Income & Growth-20.03% -2.11% N/A
Ultimate Sports Group N/A N/A N/A

CVC Income & Growth is trading at a lower price-to-earnings ratio than Ultimate Sports Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVC Income & Growth£18.73M0.16N/A-£4.94N/A
Ultimate Sports Group£1.69M0.00N/A-£0.40N/A

2.9% of CVC Income & Growth shares are held by institutional investors. 0.1% of CVC Income & Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

CVC Income & Growth beats Ultimate Sports Group on 4 of the 7 factors compared between the two stocks.

Get CVC Income & Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVCE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVCE vs. The Competition

MetricCVC Income & GrowthAsset Management IndustryFinancial SectorLON Exchange
Market Cap£2.91M£2.31B£5.79B£2.90B
Dividend Yield6.94%5.97%5.25%6.17%
P/E Ratio-0.2125.1415.92365.16
Price / Sales0.162,010.89989.7887,648.92
Price / CashN/A60.1789.1827.89
Price / BookN/A1.356.527.62
Net IncomeN/A£265.53M£1.15B£5.89B
7 Day PerformanceN/A-0.74%-0.20%0.11%
1 Month PerformanceN/A0.56%0.42%0.27%
1 Year Performance-2.78%11.73%18.42%83.47%

CVC Income & Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVCE
CVC Income & Growth
N/AGBX 1.05
+1.0%
N/A-1.9%£2.91M£18.73MN/AN/A
HOYE
Honye Financial Services
N/AN/AN/AN/A£11.10MN/AN/AN/A
MILA
Mila Resources
N/AGBX 1.50
-6.3%
N/A+454.3%£11.06MN/AN/A4
TFG
Tetragon Financial
N/AGBX 12.95
-0.4%
N/AN/A£10.84M£751.20M0.02N/A
BPCR
BioPharma Credit
N/AGBX 0.94
flat
N/A+8.7%£10.60M£132.06M0.08N/A

Related Companies and Tools


This page (LON:CVCE) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners